Literature DB >> 21486911

Relationship between mechanical and electrical remodelling in patients with cardiac resynchronization implanted defibrillators.

Nicolas Lellouche1, Carlos De Diego, Noel G Boyle, Isaac Wiener, Gina Akopyan, John S Child, Kalyanam Shivkumar.   

Abstract

AIMS: Cardiac resynchronization therapy (CRT) is associated with reverse left ventricular (LV) remodelling. However, the effects of CRT-induced mechanical remodelling on electrical remodelling, and the occurrence of ventricular arrhythmias have not been clearly established. We studied the relationship between mechanical remodelling, electrical remodelling, and the occurrence of appropriate implantable cardioverter-defibrillator (ICD) therapy 1 year after CRT. METHODS AND
RESULTS: We analysed data from 45 patients who underwent ICD-CRT implantation at our centre. Significant LV reverse remodelling was defined by a minimum 10% decrease in the LV end-diastolic diameter (LVEDd) at 1 year of follow-up. Electrocardiographic indices of dispersion of repolarization [QTc, Tpeak-Tend (Tp-e) and their dispersion] were measured immediately and 1 year post-CRT implantation. The occurrence of appropriate ICD therapy was noted for each patient. Patients with (n= 21) and without (n= 24) significant LV reverse remodelling had similar baseline characteristics. At 1 year of follow-up, patients with mechanical reverse LV remodelling exhibited a significant decrease in QTc (505 ± 42 vs. 485 ± 52 ms, P < 0.05) and Tp-e (107 ± 26 vs. 92 ± 22 ms, P < 0.0001). However, patients without mechanical LV reverse remodelling exhibited a significant increase in QT dispersion (29 ± 43 vs. 98 ± 47 ms, P = 0.002) and Tp-e dispersion (22 ± 21 vs. 54 ± 36 ms, P = 0.0001). Finally patients with mechanical LV reverse remodelling experienced a lower rate of ICD therapy (P = 0.0025) after a mean follow-up of 19 months.
CONCLUSION: Reverse LV mechanical remodelling is associated with reversal of electrical remodelling and a lower rate of appropriate ICD therapy following CRT.

Entities:  

Mesh:

Year:  2011        PMID: 21486911      PMCID: PMC3148818          DOI: 10.1093/europace/eur106

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  51 in total

Review 1.  Potential proarrhythmic effects of biventricular pacing.

Authors:  Jeffrey M Fish; Josep Brugada; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2006-06-16       Impact factor: 29.983

4.  Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender.

Authors:  Thomas P Cappola; Manya R Harsch; Mariell Jessup; William T Abraham; James B Young; Susan Petersen-Stejskal; Ted Plappert; Martin St John Sutton
Journal:  J Card Fail       Date:  2006-04       Impact factor: 5.712

5.  Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial.

Authors:  Peter Carson; Inder Anand; Christopher O'Connor; Brian Jaski; Jonathan Steinberg; Amy Lwin; JoAnn Lindenfeld; Jalal Ghali; Jalil Ghali; Jodi H Barnet; Arthur M Feldman; Michael R Bristow
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

6.  Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements.

Authors:  C Tei; R A Nishimura; J B Seward; A J Tajik
Journal:  J Am Soc Echocardiogr       Date:  1997-03       Impact factor: 5.251

7.  Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome.

Authors:  Jesus Castro Hevia; Charles Antzelevitch; Francisco Tornés Bárzaga; Margarita Dorantes Sánchez; Francisco Dorticós Balea; Roberto Zayas Molina; Miguel A Quiñones Pérez; Yanela Fayad Rodríguez
Journal:  J Am Coll Cardiol       Date:  2006-04-17       Impact factor: 24.094

Review 8.  Left atrial size: physiologic determinants and clinical applications.

Authors:  Walter P Abhayaratna; James B Seward; Christopher P Appleton; Pamela S Douglas; Jae K Oh; A Jamil Tajik; Teresa S M Tsang
Journal:  J Am Coll Cardiol       Date:  2006-06-20       Impact factor: 24.094

9.  Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).

Authors:  Martin G St John Sutton; Ted Plappert; Kathryn E Hilpisch; William T Abraham; David L Hayes; Edward Chinchoy
Journal:  Circulation       Date:  2006-01-09       Impact factor: 29.690

10.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

View more
  5 in total

1.  The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy.

Authors:  András Mihály Boros; Gábor Széplaki; Péter Perge; Zsigmond Jenei; Zsolt Bagyura; Endre Zima; Levente Molnár; Astrid Apor; Dávid Becker; László Gellér; Zoltán Prohászka; Béla Merkely
Journal:  Europace       Date:  2015-05-12       Impact factor: 5.214

Review 2.  miR-133: A Suppressor of Cardiac Remodeling?

Authors:  Ning Li; Heng Zhou; Qizhu Tang
Journal:  Front Pharmacol       Date:  2018-08-17       Impact factor: 5.810

3.  Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia.

Authors:  Christian Eickholt; Marcus Siekiera; Kiriakos Kirmanoglou; Astrid Rodenbeck; Nicole Heussen; Patrick Schauerte; Artur Lichtenberg; Jan Balzer; Tienush Rassaf; Stefan Perings; Malte Kelm; Dong-In Shin; Christian Meyer
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

4.  Acute and Chronic Changes and Predictive Value of Tpeak-Tend for Ventricular Arrhythmia Risk in Cardiac Resynchronization Therapy Patients.

Authors:  Cong Xue; Wei Hua; Chi Cai; Li-Gang Ding; Zhi-Min Liu; Xiao-Han Fan; Yun-Zi Zhao; Shu Zhang
Journal:  Chin Med J (Engl)       Date:  2016-09-20       Impact factor: 2.628

5.  Influence of the Right Ventricular Lead Location on Ventricular Arrhythmias in Cardiac Resynchronization Therapy.

Authors:  Hao Su; Pei Bao; Kang-Yu Chen; Ji Yan; Jian Xu; Fei Yu; Dong-Mei Yang
Journal:  Chin Med J (Engl)       Date:  2018-10-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.